Postmenopausal Symptoms Clinical Trials
2 recruiting trials for Postmenopausal Symptoms. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Postmenopausal Symptoms clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University Hospital, Ghent (1), Bespoke Clinical Research (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is blood take (procedure, 1 trial), followed by N/A Observational Registry.
Track Postmenopausal Symptoms trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Hormone Replacement Trial Against ALzheimers' Disease
The influence of postmenopausal hormone treatment on dementia is not clear. Dysfunctions in the metabolism of amyloid in the disease of Alzheimer result in an elevated presence of...
Virtual perI-/Menopause Registry of AusTrALia
13 million (50.7%) Australians are born with ovaries, 14% (\~3 million) are currently aged 40-59 yrs, \& all such who live to midlife will experience menopause, defined as \>12...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Postmenopausal Symptoms, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Postmenopausal Symptoms, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Postmenopausal Symptoms, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.